Drug Guide
Ketotifen Fumarate
Classification
Therapeutic: Antihistamine/Anti-allergic agent
Pharmacological: H1 antihistamine, mast cell stabilizer
FDA Approved Indications
- Relief of allergic conjunctivitis symptoms such as itching, redness, and swelling
Mechanism of Action
Ketotifen Fumarate inhibits the release of allergic mediators from mast cells and blocks H1 histamine receptors, reducing allergic symptoms.
Dosage and Administration
Adult: 1 drop in affected eye(s) twice daily, approximately 8-12 hours apart
Pediatric: Age 3 years and older: 1 drop in affected eye(s) twice daily; not recommended for children under 3 years
Geriatric: No specific dose adjustments necessary, use with caution as with other medications
Renal Impairment: No specific dosing adjustments established; use cautiously
Hepatic Impairment: No specific dosing adjustments established
Pharmacokinetics
Absorption: Limited systemic absorption when used topically
Distribution: Primarily local in eye tissues
Metabolism: Metabolized minimally; mostly remains localized
Excretion: Excreted in urine; systemic absorption is minimal
Half Life: Approximately 3 hours systemically, but topical ocular half-life not well-defined
Contraindications
- Hypersensitivity to ketotifen or other components
Precautions
- Use with caution in patients with active ocular infections or recent ocular surgery; for use in children only if above 3 years
Adverse Reactions - Common
- Ocular irritation or stinging (Common)
- Redness (Common)
Adverse Reactions - Serious
- Eye pain or sensitivity to light (Rare)
- Visual disturbances (Rare)
- Allergic reactions such as swelling or rash (Rare)
Drug-Drug Interactions
- No significant interactions reported with ocular use
Drug-Food Interactions
- No known interactions
Drug-Herb Interactions
- No known interactions
Nursing Implications
Assessment: Assess for existing allergies and ocular infections before use
Diagnoses:
- Risk for allergy-related ocular discomfort
Implementation: Administer drops as directed, instruct on proper technique, and monitor response and adverse effects
Evaluation: Determine symptom relief and absence of adverse reactions
Patient/Family Teaching
- Use medication exactly as prescribed.
- Do not touch dropper tip to eye or skin to avoid contamination.
- Report any eye pain, changes in vision, or persistent irritation.
Special Considerations
Black Box Warnings:
- None
Genetic Factors: None specific
Lab Test Interference: No known interference
Overdose Management
Signs/Symptoms: If ingested in large amounts, systemic effects such as drowsiness or agitation may occur
Treatment: Supportive care; activated charcoal if ingestion is recent; seek immediate medical attention
Storage and Handling
Storage: Store at room temperature, away from light and moisture
Stability: Stable until printed expiration date when stored properly